Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Freedman RA, Gelman RS, Agar NYR, Santagata S, Randall EC, Gimenez-Cassina Lopez B, Connolly RM, Dunn IF, Van Poznak CH, Anders CK, Melisko ME, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Moy B, Blackwell KL, Puhalla SL, Ibrahim N, Moynihan TJ, Nangia J, Tung N, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU; Translational Breast Cancer Research Consortium (TBCRC).

Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30657-3. doi: 10.1016/j.clbc.2019.07.011. [Epub ahead of print]

PMID:
31558424
2.

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, Ibrahim N, Moynihan TJ, O'Sullivan CC, Nangia J, Niravath P, Tung N, Pohlmann PR, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU; Translational Breast Cancer Research Consortium.

J Clin Oncol. 2019 May 1;37(13):1081-1089. doi: 10.1200/JCO.18.01511. Epub 2019 Mar 12.

PMID:
30860945
3.

Pathology, imaging, and treatment of cardiac tumours.

Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW.

Nat Rev Cardiol. 2017 Sep;14(9):536-549. doi: 10.1038/nrcardio.2017.47. Epub 2017 Apr 24. Review.

PMID:
28436488
4.

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

Somlo G, Frankel PH, Arun BK, Ma CX, Garcia AA, Cigler T, Cream LV, Harvey HA, Sparano JA, Nanda R, Chew HK, Moynihan TJ, Vahdat LT, Goetz MP, Beumer JH, Hurria A, Mortimer J, Piekarz R, Sand S, Herzog J, Van Tongeren LR, Ferry-Galow KV, Chen AP, Ruel C, Newman EM, Gandara DR, Weitzel JN.

Clin Cancer Res. 2017 Aug 1;23(15):4066-4076. doi: 10.1158/1078-0432.CCR-16-2714. Epub 2017 Mar 29.

5.

Timothy Moynihan, MD, on 'Death Cafés' and the Importance of Discussing End-of-Life Issues With Your Patients.

Moynihan TJ.

Oncology (Williston Park). 2015 Dec;29(12):904-5. No abstract available.

6.

Low level of hepatitis B virus screening among patients receiving chemotherapy.

Wi CI, Loo NM, Larson JJ, Moynihan TJ, Madde NR, Grendahl DC, Alberts SR, Kim WR.

Clin Gastroenterol Hepatol. 2015 May;13(5):970-5; quiz e51. doi: 10.1016/j.cgh.2014.10.032. Epub 2014 Nov 6.

7.

Cryoablation of sternal metastases for pain palliation and local tumor control.

Hegg RM, Kurup AN, Schmit GD, Weisbrod AJ, Atwell TD, Olivier KR, Moynihan TJ, Callstrom MR.

J Vasc Interv Radiol. 2014 Nov;25(11):1665-70. doi: 10.1016/j.jvir.2014.08.011. Epub 2014 Sep 23.

PMID:
25255705
8.

End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care.

Thompson CA, Hugo SE, Swetz KM, Novotny PJ, Sloan JA, Loprinzi CL, Moynihan TJ, Shanafelt TD.

BMJ Support Palliat Care. 2013 Jun;3(2):181-7. doi: 10.1136/bmjspcare-2012-000295. Epub 2013 Mar 9.

PMID:
24644566
9.

The elephant in the room-your patient is dying: a teachable moment.

Tajouri TH, Moynihan TJ.

JAMA Intern Med. 2014 Feb 1;174(2):185. doi: 10.1001/jamainternmed.2013.12822. No abstract available.

PMID:
24343114
10.

Hospice and where the doctor can be.

Litzow MR, Moynihan TJ.

J Clin Oncol. 2013 Oct 10;31(29):3723. doi: 10.1200/JCO.2013.51.6492. Epub 2013 Sep 9. No abstract available.

PMID:
24019542
11.

In chemotherapy for lung cancer, sometimes less is more.

Roeland E, Loprinzi C, Moynihan TJ, Smith TJ, Temel J.

J Natl Compr Canc Netw. 2013 Mar 1;11(3):232-5. No abstract available.

PMID:
23486449
12.

Palliative communications: addressing chemotherapy in patients with advanced cancer.

Kadakia KC, Moynihan TJ, Smith TJ, Loprinzi CL.

Ann Oncol. 2012 Apr;23 Suppl 3:29-32. doi: 10.1093/annonc/mds085.

PMID:
22628413
13.

Targeting the symptoms of lung cancer, not just the disease.

Robinson SI, Moynihan TJ.

J Support Oncol. 2012 Jan-Feb;10(1):10-1. doi: 10.1016/j.suponc.2011.07.003. Epub 2011 Sep 23. No abstract available.

PMID:
22005219
14.

Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment.

Lewis MA, Hendrickson AW, Moynihan TJ.

CA Cancer J Clin. 2011 Sep-Oct;61(5):287-314. doi: 10.3322/caac.20124. Epub 2011 Aug 19. Review. Erratum in: CA Cancer J Clin. 2011 Nov-Dec;61(6):420. Dosage error in article text.

15.

An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer.

Pachman DR, Swetz KM, Mauck WD, Pingree MJ, Hoelzer BC, Haugland AJ, Novotny PJ, Sloan JA, Moynihan TJ, Rho RH.

J Support Oncol. 2011 May-Jun;9(3):113-9.

PMID:
21702403
16.

Palliative care consultations in patients with cancer: a mayo clinic 5-year review.

Kamal AH, Swetz KM, Carey EC, Cheville AL, Liu H, Ruegg SR, Moynihan TJ, Sloan JA, Kaur JS.

J Oncol Pract. 2011 Jan;7(1):48-53. doi: 10.1200/JOP.2010.000067.

17.

Characterizing care of hospice patients in the hospital setting.

Olsen ML, Bartlett AL, Moynihan TJ.

J Palliat Med. 2011 Feb;14(2):185-9. doi: 10.1089/jpm.2010.0241. Epub 2011 Jan 21.

18.

Safe use of opioids to manage pain in patients with cirrhosis.

Swetz KM, Carey EC, Rho RH, Mauck WD, Whitford KJ, Moynihan TJ, Kaur JS, Coyne PJ, Smith TJ.

Mayo Clin Proc. 2010 Oct;85(10):959; author reply 960. doi: 10.4065/mcp.2010.0294. No abstract available.

19.

How to organize a fellowship program: lessons learned and how to include accreditation council for graduate medical education competencies in the curriculum.

Collichio FA, Kosty MP, Moynihan TJ, Davis TH, Stewart JA.

J Clin Oncol. 2010 Aug 1;28(22):3659-67. doi: 10.1200/JCO.2010.28.1964. Epub 2010 Jul 6. No abstract available.

PMID:
20606079
20.

Training programs in blood diseases: Mayo Clinic Rochester Hematology-Oncology Fellowship Program.

Chee CE, Tan TS, Moynihan TJ, Wolanskyj AP.

Am J Hematol. 2010 Jun;85(6):447-8. doi: 10.1002/ajh.21714. No abstract available.

21.

Metastatic lobular breast adenocarcinoma presenting as cauda equina syndrome.

Staff NP, Bosch EP, Engelstad J, Moynihan TJ, Spinner RJ, Dyck PJ.

J Peripher Nerv Syst. 2010 Mar;15(1):75-8. doi: 10.1111/j.1529-8027.2010.00255.x. No abstract available.

PMID:
20433609
22.

Oncologic emergencies.

Behl D, Hendrickson AW, Moynihan TJ.

Crit Care Clin. 2010 Jan;26(1):181-205. doi: 10.1016/j.ccc.2009.09.004. Review.

PMID:
19944281
23.

Desmoplastic small round cell tumor of the central nervous system: report of two cases and review of the literature.

Neder L, Scheithauer BW, Turel KE, Arnesen MA, Ketterling RP, Jin L, Moynihan TJ, Giannini C, Meyer FB.

Virchows Arch. 2009 Apr;454(4):431-9. doi: 10.1007/s00428-009-0750-x. Epub 2009 Mar 5.

PMID:
19263077
24.

Phase I versus palliative care: striking the right balance.

Schapira L, Moynihan TJ, von Gunten CF, Smith TJ.

J Clin Oncol. 2009 Jan 10;27(2):307-8. doi: 10.1200/JCO.2008.20.7803. Epub 2008 Dec 8. No abstract available.

PMID:
19064948
25.

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.

Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, Moynihan TJ, Buckner JC.

J Neurooncol. 2008 Nov;90(2):201-4. doi: 10.1007/s11060-008-9645-y. Epub 2008 Jul 17.

PMID:
18633576
26.

Use of a palliative care order set to improve resident comfort with symptom management in palliative care.

Jarabek BR, Jama AA, Cha SS, Ruegg SR, Moynihan TJ, McDonald FS.

Palliat Med. 2008 Jun;22(4):343-9. doi: 10.1177/0269216308090169.

PMID:
18541638
27.

Malignant primary cardiac tumors: review of a single institution experience.

Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, Moynihan TJ.

Cancer. 2008 Jun;112(11):2440-6. doi: 10.1002/cncr.23459.

28.

Missed opportunities: commentary on "The sentinel".

Moynihan TJ, von Gunten CF.

J Clin Oncol. 2008 Apr 1;26(10):1762-3. doi: 10.1200/JCO.2008.16.5027. No abstract available.

PMID:
18375909
29.

Applying quality-of-life data formally and systematically into clinical practice.

Frost MH, Bonomi AE, Cappelleri JC, Schünemann HJ, Moynihan TJ, Aaronson NK; Clinical Significance Consensus Meeting Group.

Mayo Clin Proc. 2007 Oct;82(10):1214-28.

PMID:
17908528
30.

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.

Davis ID, Wiseman GA, Lee FT, Gansen DN, Hopkins W, Papenfuss AT, Liu Z, Moynihan TJ, Croghan GA, Adjei AA, Hoffman EW, Ingle JN, Old LJ, Scott AM.

Cancer Immun. 2007 Aug 17;7:13.

31.

Preparing ourselves, our trainees, and our patients: a commentary on truthtelling.

Moynihan TJ, Schapira L.

J Clin Oncol. 2007 Feb 1;25(4):456-7. No abstract available.

PMID:
17264346
32.

Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review.

Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ.

J Clin Oncol. 2006 Dec 1;24(34):5457-64. Review.

PMID:
17135649
33.

Oncologic emergencies: diagnosis and treatment.

Halfdanarson TR, Hogan WJ, Moynihan TJ.

Mayo Clin Proc. 2006 Jun;81(6):835-48. Review. Erratum in: Mayo Clin Proc. 2006 Nov;81(11):1509.

PMID:
16770986
34.

Cancer-related fatigue: an update.

Sood A, Moynihan TJ.

Curr Oncol Rep. 2005 Jul;7(4):277-82. Review.

PMID:
15946587
35.

Mastering the art of oncology.

Loprinzi CL, Moynihan TJ.

Minn Med. 2005 Apr;88(4):34-5, 54. No abstract available.

PMID:
15940891
36.

As-needed morphine: yes, but at what dose and at what interval?

Ryan M, Moynihan TJ, Loprinzi CL.

J Clin Oncol. 2005 Jun 1;23(16):3849-52. Review. No abstract available.

PMID:
15923580
37.

Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.

Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ.

J Support Oncol. 2003 Nov-Dec;1(4):274-8.

PMID:
15334869
38.

Use of opioids in the treatment of severe pain in terminally ill patients--dying should not be painful.

Moynihan TJ.

Mayo Clin Proc. 2003 Nov;78(11):1397-401. Review. Erratum in: Mayo Clin Proc. 2003 Dec;78(12):1579.

PMID:
14601699
39.

Ependymal tumors.

Moynihan TJ.

Curr Treat Options Oncol. 2003 Dec;4(6):517-23. Review.

PMID:
14585232
40.

"But doctor, what have I got to lose...?".

Harnett PR, Moynihan TJ.

J Clin Oncol. 2003 May 1;21(9 Suppl):27s-29s. No abstract available.

PMID:
12743184
41.

Some unusual complications of malignancies: case 2. Marantic endocarditis in advanced cancer.

Fanale MA, Zeldenrust SR, Moynihan TJ.

J Clin Oncol. 2002 Oct 1;20(19):4111-4. No abstract available.

PMID:
12351608
42.

Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA; Clinical Significance Consensus Meeting Group.

Mayo Clin Proc. 2002 Jun;77(6):561-71. Review.

PMID:
12059127
43.

"But doctor, what have i got to lose...?".

Harnett PR, Moynihan TJ.

J Clin Oncol. 2001 Jul 1;19(13):3294-6. No abstract available.

PMID:
11432900
44.

The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

Buckner JC, Moynihan TJ.

N Engl J Med. 2001 Mar 1;344(9):686; author reply 687-8. No abstract available.

PMID:
11229337
45.

The role of chemotherapy in the treatment of primary tumors of the central nervous system.

Moynihan TJ, Grossman SA.

Cancer Invest. 1994;12(1):88-97. Review. No abstract available.

PMID:
8281468
46.

Neoplastic meningitis.

Grossman SA, Moynihan TJ.

Neurol Clin. 1991 Nov;9(4):843-56. Review.

PMID:
1722000

Supplemental Content

Loading ...
Support Center